Renovorx Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.81

-0.04 (-5.08%)

As of May 16, 2:23 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +4,514.3% upside

Low Target $24.30

Average Target $37.45

High Target $44.03

Current Price $0.81

Current
$0.81

Target
$37.45

$24.30 $37.45 avg $44.03

Scenario Analysis

Bear Case

$24.30

2,894.1%

Low target

Base Case

$37.45

+4,514.3%

Avg target

Bull Case

$44.03

+5,325.1%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$1.45

-44.0% from high

52-Week Low

$0.70

+15.8% from low

Target vs 52W High

$37.45

+2,482.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%